BrainStorm Cell Therapeutics Inc. Therapy Treatment Shown To Be More Effective Than Other Current Potential Stem Cell Treatments in Tel Aviv University Study

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the company’s therapeutic approach for treating neurodegenerative diseases was shown to be superior to other current potential stem cell treatments.

Back to news